Boston Biomedical Research Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 64 Grove Street, Watertown, MA 02472, USA.
Biochem Biophys Res Commun. 2010 Mar 19;393(4):746-50. doi: 10.1016/j.bbrc.2010.02.074. Epub 2010 Feb 18.
Transporter (carrier) proteins of the inner mitochondrial membrane link metabolic pathways within the matrix and the cytosol with transport/exchange of metabolites and inorganic ions. Their strict control of these fluxes is required for oxidative phosphorylation. Understanding the ternary complex transport mechanism with which most of these transporters function requires an accounting of the number and interactions of their subunits. The phosphate transporter (PTP, Mir1p) subunit readily forms homodimers with intersubunit affinities changeable by mutations. Cys28, likely at the subunit interface, is a site for mutations yielding transport inhibition or a channel-like transport mode. Such mutations yield a small increase or decrease in affinity between the subunits. The PTP inhibitor N-ethylmaleimide decreases subunit affinity by a small amount. PTP mutations that yield the highest (40%) and the lowest (2%) liposome incorporation efficiencies (LIE) are clustered near Cys28. Such mutant subunits show the lowest and highest subunit affinities respectively. The oxaloacetate transporter (Oac1p) subunit has an almost twofold lower affinity than the PTP subunit. The Oac1p, dicarboxylate (Dic1p) and PTP transporter subunits form heterodimers with even lower affinities. These results form a firm basis for detailed studies to establish the effect of subunit affinities on transport mode and activity and for the identification of the mechanism that prevents formation of heterodimers that surely will negatively impact oxidative phosphorylation and ATP levels with serious consequences for the cell.
线粒体膜转运蛋白将基质和细胞质中的代谢途径联系起来,实现代谢物和无机离子的运输/交换。它们对这些流量的严格控制是氧化磷酸化所必需的。要理解大多数转运蛋白的三元复合物转运机制,需要考虑其亚基的数量和相互作用。磷酸转运蛋白(PTP,Mir1p)亚基容易形成具有亚基亲和力可变的同源二聚体。Cys28 可能位于亚基界面,是突变导致运输抑制或类似通道的运输模式的位点。这些突变导致亚基之间的亲和力略有增加或减少。PTP 抑制剂 N-乙基马来酰亚胺(N-ethylmaleimide)会使亚基亲和力略有降低。产生最高(40%)和最低(2%)脂质体掺入效率(LIE)的 PTP 突变集中在 Cys28 附近。这种突变的亚基分别表现出最低和最高的亚基亲和力。草酰乙酸转运蛋白(Oac1p)亚基的亲和力比 PTP 亚基低近两倍。Oac1p、二羧酸(Dic1p)和 PTP 转运蛋白亚基形成异二聚体,亲和力更低。这些结果为详细研究奠定了坚实的基础,以确定亚基亲和力对运输模式和活性的影响,并确定防止形成异二聚体的机制,这肯定会对氧化磷酸化和 ATP 水平产生负面影响,对细胞造成严重后果。